系统性硬化症不同自身抗体组共享与独特分子特征的多组学分析
该研究纳入166例系统性硬化症(SSc)患者,按抗体状态分层为ACA、ATA、ARA、抗U1RNP、抗U3RNP、抗Ku和抗Th/To组,进行血浆蛋白组学、PBMC转录组学、免疫细胞表型和血浆代谢组学分析。结果显示所有SSc亚组均存在内皮损伤、细胞外基质沉积、I型干扰素信号上调和调节性B细胞减少等共同致病特征,同时各抗体亚组表现出独特疾病机制。研究提示基于自身抗体的分层有助于SSc精准管理。
要点
- 所有SSc亚组共享内皮损伤、细胞外基质沉积、I型干扰素信号上调和调节性B细胞减少。
- ACA组以钙质沉着为特征,ATA组以代谢氧化应激为特征。
- ARA组致癌信号激活,U1RNP组染色质重塑活性增强。
核心结论
- SSc相关自身抗体亚组既存在共同致病特征,又表现出与临床特征相关的独特分子机制。
- 基于自身抗体的分层具有指导SSc精准管理和生物标志物驱动方法的潜力。
研究设计与样本
- 研究纳入166例SSc患者,按抗体状态分层:ACA=55、ATA=58、ARA=24、抗U1RNP=12、抗U3RNP=8、抗Ku=4、抗Th/To=5。
- 采用多组学分析,包括血浆蛋白组学、外周血单个核细胞(PBMC)转录组学、免疫细胞表型和血浆代谢组学。
主要发现
- 所有SSc亚组均显示内皮损伤和细胞外基质沉积(血浆蛋白组学)、I型干扰素信号上调(转录组学)及调节性B细胞减少(免疫细胞表型)。
- ACA阳性患者表现为钙质沉着,ATA阳性患者表现为代谢氧化应激。
- ARA阳性患者表现为致癌信号激活,U1RNP阳性患者表现为染色质重塑活性增强。
- U3RNP/Ku组表现为肌肉受累,Th/To阳性病例表现为与肺动脉高压相关的独特代谢信号。
临床怎么用
- 基于自身抗体的分层可帮助识别SSc患者不同的分子机制和临床特征。
- 多组学特征有望作为生物标志物指导SSc的精准管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Each autoantibody associated with systemic sclerosis (SSc) is linked to distinct clinical features, suggesting underlying molecular heterogeneity. Although studies have characterised molecular signatures in anticentromere (ACA), antitopoisomerase I (ATA), and anti-RNA polymerase III (ARA) antibodies in patients who are SSc-positive, less frequent autoantibody groups remain unexplored. Our study employed multiomics analysis to identify shared and unique molecular profiles across SSc-associated autoantibody subgroups. METHODS: We enrolled 166 patients with SSc stratified by antibody status (ACA = 55, ATA = 58, ARA = 24, anti-U1 ribonucleoprotein [U1RNP] = 12, anti-U3 ribonucleoprotein [U3RNP] = 8, anti-Ku [Ku] = 4, and anti-Th/To [Th/To] = 5). We performed multiomics profiling, including plasma proteomics, peripheral blood mononuclear cells (PBMCs) transcriptomics, immune cell phenotyping, and plasma metabolomics to identify shared and distinct features across groups. RESULTS: All SSc subsets demonstrated common pathogenic features, including endothelial injury, extracellular matrix deposition identified by plasma proteomics, upregulated type I interferon (IFN) signalling revealed by transcriptomic analysis, and decreased regulatory B cells observed by immune cell profiling. Meanwhile, each autoantibody subgroup exhibited unique disease mechanisms, such as calcinosis in ACA-positive patients, metabolic oxidative stress in ATA-positive patients, activation of oncogenic signalling in ARA-positive patients, enhanced chromatin remodelling activity in U1RNP-positive patients, muscle involvement in U3RNP/Ku groups, and unique metabolic signalling related to pulmonary hypertension in Th/To-positive cases. CONCLUSIONS: Our study addresses a critical gap by providing a comprehensive multiomics characterisation of both common and rare SSc-associated autoantibody groups, revealing shared and distinct molecular signatures that correlate with clinical features. Our findings highlight the potential for autoantibody-based stratification to guide precision management of SSc, paving the way for biomarker-driven approaches in SSc care.
引用
- Lin W, Zhao Z, Jia C, et al. Shared and unique molecular signatures across different autoantibody groups in systemic sclerosis: a multiomics analysis. Ann Rheum Dis. 2025. PMID: 41419424. doi:10.1016/j.ard.2025.11.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。